Financials
- Market Capitalization 208.84 M
- Employee 30
- Founded 2014
- CEO N/A
- Website www.novabridge.com
- Headquarter Cayman Islands
- FIGI BBG00QQ8DFK6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.29
ratio cours/chiffre d'affaires
876.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3594 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.43 USD | +1.72% | -6.26% | +0.24% | -82.33% | 212.62 M USD | ||
| 3606 | OTLK Outlook Therapeutics, Inc. - Common Stock | 1.73 USD | +11.61% | +20.98% | +31.06% | +319.39% | 209.09 M USD | ||
| 3612 | CLLS Cellectis S.A. - American Depositary Shares | 2.89 USD | 0.00% | -10.25% | -6.77% | +25.65% | 207.36 M USD | ||
| 3613 | IMUX Immunic, Inc. - Common Stock | 15.22 USD | +3.96% | -1.55% | +9.03% | +1690.59% | 207.32 M USD |